Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular edema ...

An announcement from Opthea Limited ( (AU:OPT) ) is now available.

Neovascular AMD is an advanced form of the condition, also known as “exudative AMD" or “wet macular degeneration.” The wet form is less common than the dry form of AMD, occurring in roughly ...

SolidddVision smart glasses aim to restore vision for people living with macular degeneration, a condition that affects ...

You might develop blurry vision or other trouble seeing. This could be a sign of age-related macular degeneration (AMD). Wet AMD is the advanced form of the disease. It happens when new blood ...

Citi has initiated coverage of EyePoint (EYPT) with a buy rating, stating it sees the company's drug Duravyu as well-positioned to compete in the wAMD market. Read more here.

Shares of Outlook Therapeutics jumped after the company said it continues to progress the development of its treatment for wet age-related macular degeneration, which causes blurred or reduced central ...

A more severe form of macular degeneration, neovascular or wet AMD, sets on much more rapidly and can lead to complete central vision blindness. With this type, abnormal blood vessel develop ...

Age related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal ...